Clinical Trials Browser

INDUSTRY × Inotuzumab Ozogamicin × 90 days × Clear all

NCT05748171 2026-05-14

A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL

Phase 2 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma